돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1787461생성일: 2026년 10월 25일

Imidazole → 1-((1R)-1,5-Dimethylhexyl)octahydro-7a-methyl-4H-inden-4-one, (1R,3aR,7aR)-

https://huagongshe.com/reaction/1787461

반응식

참여 물질

역할이름HCID투입량
반응물ImidazoleHCID 795—
반응물Acetic AnhydrideHCID 7918—
반응물Benzenesulfonic acid, 4-methyl-, compd. with pyridine (1:1)HCID 466102—
반응물HCID 178418287HCID 178418287—
반응물ButyllithiumHCID 178418339—
촉매Sodium amalgamHCID 9837419—
용매PyridineHCID 1049—
용매HexaneHCID 8058—
용매Ethyl AcetateHCID 8857—
생성물1-((1R)-1,5-Dimethylhexyl)octahydro-7a-methyl-4H-inden-4-one, (1R,3aR,7aR)-HCID 10587733—

반응 단계

Compounds of formula I, formula IA, and formula IB were prepared using the methods shown in Schemes I, IIA, and IIB. Compound 1 is obtained by ozonolysis of ergocalciferol or vitamin D2 as described by Sicinski et al. (J. Med. Chem. 41, 4662-4672, 1998). Compound 1 is reduced with borohydride to produce the dihydroxy compound 2. These reactions can be followed by thin layer chromatography (TLC) using a solvent system of 10% ethyl acetate in hexane. Treatment of 2 with acetic anhydride in pyridine provides the acetate compound 3. Compound 3 is then treated with triethylsilyl trifluoromethane sulfonate followed by base hydrolysis (heating with KOH in methanol) to yield compound 4. Again, these reactions are followed by the same TLC system as above. Compound 4 is oxidized with sulfur trioxide in pyridine, dimethylsulfoxide and triethylamine to provide 5. The reaction is followed by TLC using 10% in acetic acid. Treatment of 5 with sodium bicarbonate to epimerize the compound followed by reduction with sodium borohydride in methanol provides alcohol 6 and is detected by TLC with 20% ethyl acetate in hexane. Compound 6 is then oxidized using the reagents shown in Scheme IIA to produce compound 7 which is in turn was reacted with the stereospecific sulfone (compound 8) in the presence of n-BuLi (Scheme IIB). Sulfone 8 was prepared using starting materials obtained from the Aldrich Chemical Company (Milwaukee, Wis.) using the procedures disclosed in U.S. Pat. No. 5,750,746, which issued to DeLuca et al. on May 12, 1998. Acetylation of this compound was performed using acetic anhydride and pyridine resulting in compound 9, which was confirmed by TLC (10% ethyl acetate in hexane). Compound 9 was then converted to compound 10, by reaction with a sodium amalgam. The presence of compound 10, was confirmed using TLC (10% ethyl acetate in hexane). Deprotection of compound 10 was done using pyridinium p-toluene sulfonate, and the reaction followed by TLC with 35% ethyl acetate in hexane. Oxidation of compound 11 was accomplished by reaction with pyridinium chlorochromate. A trimethylsilyl group was then added in the presence of imidazole to provide protected compound 13. Products 12 and 13 were detected by TLC with 35% ethyl acetate in hexane. A Wittig-Horner condensation of the protected Grundmann's Ketone (Compound 13) with the phosphine oxide (Compound 14) in the presence of n-BuLi was performed. The resulting product (Compound 15) was confirmed by TLC (20% ethyl acetate in hexane). Finally, the target compound (Compound 16) was generated by deprotection in the presence of tetrabutyl ammonium fluoride. The reaction was followed by TLC with 10% methanol in chloroform. Additional confirmation of the end product is described below:

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07511030B2
출처 데이터셋uspto-grants-2009_03
ORD IDord-28cafd2b360c4b4785e7637dd8c1b140
출처 메모uspto-grants-2009_03